Promising biomedical subcutaneous delivery system in opioid disaccustom process: in vitro/in vivo evaluation of Naloxone microparticles on antagonist effect of Morphine.

[1]  J. Kaur,et al.  Sustained drug delivery strategies for treatment of common substance use disorders: Promises and challenges. , 2022, Journal of controlled release : official journal of the Controlled Release Society.

[2]  C. Goicoechea,et al.  SGK1.1 isoform is involved in nociceptive modulation, offering a protective effect against noxious cold stimulus in a sexually dimorphic manner , 2021, Pharmacology Biochemistry and Behavior.

[3]  M. Kariisa,et al.  Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths — United States, 2013–2019 , 2021, MMWR. Morbidity and mortality weekly report.

[4]  Caitlin A. Madison,et al.  Novel oral nanoparticle formulation of sustained release naloxone with mild withdrawal symptoms in mice. , 2020, ACS chemical neuroscience.

[5]  D. Whiting,et al.  Covalent Poly(lactic acid) Nanoparticles for the Sustained Delivery of Naloxone. , 2019, ACS applied bio materials.

[6]  P. Skolnick.  On the front lines of the opioid epidemic: Rescue by naloxone. , 2018, European journal of pharmacology.

[7]  Irina Vetter,et al.  Methods Used to Evaluate Pain Behaviors in Rodents , 2017, Front. Mol. Neurosci..

[8]  Mona A. Gandhi,et al.  Comparing methods of naloxone administration: A narrative review. , 2017, Journal of opioid management.

[9]  Beneitez Maria Cristina,et al.  Critical Quality Attributes of Control Drug Release Systems and Their Impact on Rational Polymer Selection , 2017 .

[10]  M. E. Gil-Alegre,et al.  Influence of Surfactant on the Characteristics of W1/O/W2-Microparticles , 2014 .

[11]  A. Jurado,et al.  Sustained release of naltrexone from poly(n-isopropylacrylamide) microgels. , 2014, Journal of pharmaceutical sciences.

[12]  C. Ghelardini,et al.  Differentiation state affects morphine induced cell regulation in neuroblastoma cultured cells , 2013, Neuroscience Letters.

[13]  A. Kasko,et al.  Polymeric biomaterials with engineered degradation , 2013 .

[14]  V. Pillay,et al.  Optimization of a polymer composite employing molecular mechanic simulations and artificial neural networks for a novel intravaginal bioadhesive drug delivery device , 2012, Pharmaceutical development and technology.

[15]  J. Tao,et al.  Solution Behavior of PVP-VA and HPMC-AS-Based Amorphous Solid Dispersions and Their Bioavailability Implications , 2012, Pharmaceutical Research.

[16]  C. Goicoechea,et al.  Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally. , 2008, European journal of pharmacology.

[17]  Albert Dahan,et al.  Naloxone treatment in opioid addiction: the risks and benefits , 2007, Expert opinion on drug safety.

[18]  J. Zadina,et al.  Internalization and down-regulation of mu opioid receptors by endomorphins and morphine in SH-SY5Y human neuroblastoma cells , 2004, Brain Research.

[19]  L. Callado,et al.  Synthesis and opioid activity of new fentanyl analogs. , 2002, Life sciences.

[20]  M. Bertolotti,et al.  Serum time course of naltrexone and 6 beta-naltrexol levels during long-term treatment in drug addicts. , 1998, Drug and alcohol dependence.

[21]  N. Ambache,et al.  Localization of acetyl- and butyrylcholinesterases in the myenteric plexus and longitudinal muscle of the guinea-pig's ileum. , 1969, The Journal of physiology.

[22]  N. B. Eddy,et al.  Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines. , 1953, The Journal of pharmacology and experimental therapeutics.